Jacob Levi - Concepedia

Author

Jacob Levi

University of Liverpool ORCID

Also Known As

Helia Nateghi Baygi, J. Levi, Jacob A Levi, Jacob A. Levi, Jacob Levi

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Liverpool Imperial College London University College London Tehran University of Medical Sciences Cardiff and Vale University Health Board

About

Jacob Levi is an author at University of Liverpool specializing in immunology, immunodeficiencies, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	81
2	Immunology	2	2	81
3	Autoimmunity	1	1	48
4	Immune Function	1	1	48
5	Immune Regulation	1	1	48

Jacob Levi

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades Jacob Levi, Alice Raymond, Anton Pozniak, BMJ Global Health	2016	337
The Joint United Nations Programme on HIV/AIDS 95–95–95 targets: worldwide clinical and cost benefits of generic manufacture Katherine Heath, Jacob Levi, Andrew Hill AIDS	2021	135
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial Anahita Sadeghı, Ali Asgari, Alireza Norouzi, Journal of Antimicrobial Chemotherapy	2020	129
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial Hamideh Abbaspour Kasgari, Siavash Moradi, Amir Mohammad Shabani, Journal of Antimicrobial Chemotherapy	2020	94
The Joint United Nations Programme on HIV/AIDS 95-95-95 targets: worldwide clinical and cost benefits of generic manufacture. Katherine Heath, Jacob Levi, Andrew Hill PubMed	2021	79
Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment Andrew Hill, Dzintars Gotham, Joseph Fortunak, BMJ Open	2016	67
Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial Fatemeh Roozbeh, Majid Saeedi, Reza Alizadeh‐Navaei, Journal of Antimicrobial Chemotherapy	2020	63
Estimated minimum prices and lowest available national prices for antiobesity medications: Improving affordability and access to treatment Jacob Levi, Junzheng Wang, François Venter, Obesity	2023	59
Thymic function in MHC class II–deficient patients Atar Lev, Arnon Broides, Jacob Levi, Journal of Allergy and Clinical Immunology HistocompatibilityLymphocyte DevelopmentImmunodeficienciesImmunologyImmune Regulation	2012	48
Analysis of Pharmacovigilance Databases for Dolutegravir Safety in Pregnancy Nikolien S van De Ven, Anton Pozniak, Jacob Levi, Clinical Infectious Diseases	2019	34

Page 1